Sökning: onr:"swepub:oai:gup.ub.gu.se/310209" >
The economic burden...
The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh
-
Ahmed, S. (författare)
-
Dorin, F. (författare)
-
Satter, S. M. (författare)
-
visa fler...
-
Sarker, A. R. (författare)
-
Sultana, M. (författare)
-
Gastanaduy, P. A. (författare)
-
Parashar, U. (författare)
-
Tate, J. E. (författare)
-
Heffelfinger, J. D. (författare)
-
Gurley, E. S. (författare)
-
- Khan, Jahangir Am (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa,Institute of Medicine, School of Public Health and Community Medicine
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2021
- 2021
- Engelska.
-
Ingår i: Vaccine. - : Elsevier BV. - 0264-410X .- 1873-2518. ; 39:48, s. 7082-7090
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Rotavirus is a common cause of severe acute gastroenteritis among young children. Estimation of the economic burden would provide informed decision about investment on prevention strategies (e.g., vaccine and/or behavior change), which has been a potential policy discussion in Bangladesh for several years. Methods: We estimated the societal costs of children <5 years for hospitalization from rotavirus gastroenteritis (RVGE) and incidences of catastrophic health expenditure. A total of 360 children with stool specimens positive for rotavirus were included in this study from 6 tertiary hospitals (3 public and 3 private). We interviewed the caregiver of the patient and hospital staff to collect cost from patient and health facility perspectives. We estimated the economic cost considering 2015 as the reference year. Results: The total societal per-patient costs to treat RVGE in the public hospital were 126 USD (95% CI: 116-136) and total household costs were 161 USD (95% CI: 145-177) in private facilities. Direct costs constituted 38.1% of total household costs. The out-of-pocket payments for RVGE hospitalization was 23% of monthly income and 76% of households faced catastrophic healthcare expenditures due to this expense. The estimated total annual household treatment cost for the country was 10 million USD. Conclusions: A substantial economic burden of RVGE in Bangladesh was observed in this study. Any prevention of RVGE through cost-effective vaccination or/and behavioural change would contribute to substantial economic benefits to Bangladesh. (c) 2021 Elsevier Ltd. All rights reserved.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Immunology in the medical area (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Nyckelord
- Economic burden
- Rotavirus gastroenteritis
- Diarrhea
- Costs-of-illness
- Catastrophic health expenditure
- Bangladesh
- health-care
- cost-effectiveness
- rural bangladesh
- diarrhea
- gastroenteritis
- illness
- surveillance
- expenditure
- mortality
- impact
- Immunology
- Research & Experimental Medicine
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Vaccine
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Ahmed, S.
-
Dorin, F.
-
Satter, S. M.
-
Sarker, A. R.
-
Sultana, M.
-
Gastanaduy, P. A ...
-
visa fler...
-
Parashar, U.
-
Tate, J. E.
-
Heffelfinger, J. ...
-
Gurley, E. S.
-
Khan, Jahangir A ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Immunologi inom ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Folkhälsovetensk ...
- Artiklar i publikationen
-
Vaccine
- Av lärosätet
-
Göteborgs universitet
-
Karolinska Institutet